Multiple Sclerosis Trial A separate investigation explored this compound in the context of multiple sclerosis, likely motivated by the compounds documented interactions with the dopaminergic and neuroprotective systems identified in animal research
BPC-157 also appears in published wound-healing literature, with some pre-clinical studies reporting accelerated skin incision healing in rodent models
In clinical use, BPC-157 may support healing in patients whose activities, occupations, or injuries require additional metabolic support
It is possible that the effects are additive, that they are redundant, or that combining approaches produces unexpected outcomes
Our protocols are evidence-based, using FDA-compliant peptides that have been studied for their role in healing, metabolism, and anti-aging
Concerns about potential safety and efficacy issues have turned the peptide into a kind of gray-market celebrity, where consumer safety and efficacy are almost certainly a risk